Worldwide Point-of-Care-Ultrasound Device Industry to 2023: Surge in Geriatric Population is Driving Growth

November 24, 2020

Worldwide point-of-care-ultrasound device industry devices market is predicted to reach a value of $4,494.4 million in 2030, rising from $2,096.6 million in 2019, progressing at a 7.4% CAGR during 2020-2030.

A major factor leading to the growth of the market is the increasing number of investments that are being made in the healthcare sector by a number of countries.

As per the World Bank Group, the expenditure in the global healthcare sector rose from 8.6% in 2000 to 9.9% of the GDP in 2017. In addition to this, the rising prevalence of chronic disease and surging non-government and government initiatives for facilitating better treatment are also projected to result in the growth of healthcare expenditure, thereby driving the market. The coronavirus pandemic has, however, negatively impacted the market to some extent, and recovery is only expected to occur after the third quarter of 2020.

The European region dominated the point-of-care ultrasound devices market in 2019 due to the increasing prevalence of chronic diseases, technological advancements, and rising healthcare expenditure. As per the World Health Organization, cancer is the second major cause of morbidity and death in Europe, and account for about 1.9 million deaths every years. Therefore, the need for cost-effective and innovative diagnostic solutions, such as PoCUS devices, is increasing at a swift pace in the region.

Market Dynamics

Trends

  • Technological advancements in PoCUS devices

Drivers

  • Surge in geriatric population
  • Increasing prevalence of chronic diseases
  • Increasing awareness about benefits of portable ultrasound devices
  • Increasing healthcare expenditure
  • Impact analysis of drivers on market forecast

Restraints

  • Lack of skilled sonographers
  • Stringent regulatory norms
  • Impact analysis of restraints on market forecast

Opportunities

  • Improving healthcare infrastructure in emerging economies

Companies Mentioned

  • Esaote S.p.A.
  • Mindray Bio-Medical Electronics Co. Ltd.
  • Analogic Corporation
  • General Electric Company
  • Hitachi Ltd.
  • Siemens AG
  • Fujifilm Holdings Corporation
  • Samsung Electronics Co. Ltd.
  • Koninklijke Philips N.V.
  • Canon Inc.

For more information about this report visit here.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.